Mutations of RAS, RAF, and MEK were described in a large number of tumors: for example, RAS mutations have been found in about 1/3 of all human tumors and in 15–20% of melanomas, and BRAF is mutated in 8% of human tumors and in about 40–50% of melanomas. This evidence concerns the gene MAP2K7 and melanoma.